163 related articles for article (PubMed ID: 27904780)
1. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.
Zhang T; Wu Y; Fang Z; Yan Q; Zhang S; Sun R; Khaliq J; Li Y
Am J Cancer Res; 2016; 6(11):2679-2689. PubMed ID: 27904780
[TBL] [Abstract][Full Text] [Related]
2. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
Wu F; Li J; Guo N; Wang XH; Liao YQ
Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
[TBL] [Abstract][Full Text] [Related]
5. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma.
Sremac M; Paic F; Grubelic Ravic K; Serman L; Pavicic Dujmovic A; Brcic I; Krznaric Z; Nikuseva Martic T
Oncol Lett; 2021 Dec; 22(6):822. PubMed ID: 34691249
[TBL] [Abstract][Full Text] [Related]
7. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
[TBL] [Abstract][Full Text] [Related]
8. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
[TBL] [Abstract][Full Text] [Related]
9. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
10. Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Davaadorj M; Saito Y; Morine Y; Ikemoto T; Imura S; Takasu C; Yamada S; Hiroki T; Yoshikawa M; Shimada M
Eur J Surg Oncol; 2017 Feb; 43(2):344-350. PubMed ID: 28062160
[TBL] [Abstract][Full Text] [Related]
11. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
[TBL] [Abstract][Full Text] [Related]
12. Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids.
Liu J; Zhu H; Wang H; Li J; Han F; Liu Y; Zhang W; He T; Li N; Zheng Z; Hu D
J Mol Histol; 2018 Apr; 49(2):185-193. PubMed ID: 29455276
[TBL] [Abstract][Full Text] [Related]
13. High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer.
Qu Y; Ray PS; Li J; Cai Q; Bagaria SP; Moran C; Sim MS; Zhang J; Turner RR; Zhu Z; Cui X; Liu B
Eur J Cancer; 2013 Nov; 49(17):3718-28. PubMed ID: 23927957
[TBL] [Abstract][Full Text] [Related]
14. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma.
Chang L; Lei X; Qin YU; Zeng G; Zhang X; Jin H; Wang C; Wang X; Su J
Oncol Lett; 2016 Jan; 11(1):69-74. PubMed ID: 26870169
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.
Zheng L; Sun D; Fan W; Zhang Z; Li Q; Jiang T
PLoS One; 2015; 10(2):e0118276. PubMed ID: 25719802
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer.
Zhao CH; Bu XM; Zhang N
World J Gastroenterol; 2007 Apr; 13(15):2214-7. PubMed ID: 17465504
[TBL] [Abstract][Full Text] [Related]
18. RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer.
Lv SL; Zhou X; Li YJ; Luo LY; Huang DQ
J Cancer; 2023; 14(15):2784-2797. PubMed ID: 37781074
[No Abstract] [Full Text] [Related]
19. Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration.
Yin T; Zhang Y; Zhao Y; Zhang X; Han S; Wang Y; Yang B
Heliyon; 2024 May; 10(9):e30603. PubMed ID: 38726149
[TBL] [Abstract][Full Text] [Related]
20. Expression of RBMS3 in Breast Cancer Progression.
Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
